IDC MarketScape Positions Accenture a Leader in Life Science Sales and Marketing IT Outsourcing Services
28 Abril 2022 - 8:59AM
Business Wire
Accenture is recognized by its customers for
its technical capabilities and life science industry expertise
Accenture (NYSE: ACN) is positioned as a leader in the IDC
MarketScape analysis of life science sales and marketing IT
outsourcing services in 2022.
The report — "IDC MarketScape Worldwide Life Science Sales and
Marketing IT Outsourcing Services 2022 Vendor Assessment" (Doc #
US41808017e_Accenture, March 2022) — analyzes 11 service providers
offering IT outsourcing (ITO) solutions for sales and marketing
processes in the life science industry. It reviews both
quantitative and qualitative characteristics that define current
market demands and expected buyer needs.
The report cites several notable Accenture strengths:
- Accenture has extensive experience working with life sciences
companies in all three major areas: pharmaceutical, biotech, and
medical devices.
- Accenture reinforced its life science portfolio with the
acquisitions of Enterprise System Partners (ESP), a consulting and
manufacturing services provider for the life science industry
headquartered in Ireland, and OpusLine of France, among
others.
- Accenture has diversified its life science customer portfolio
significantly in recent years, with sales roughly split between
companies over and under $1 billion, with a significant number of
engagements spread across North America, Europe, and
Asia/Pacific.
- Accenture has 25 delivery centers based in five continents and
a large and experienced team of life science professionals.
- In life science sales and marketing, Accenture is known by its
customers for its technical capabilities and life science industry
expertise.
The report also mentions Accenture's INTIENT Patient platform, a
product suite that delivers outcome-based services to support
patient experiences from pre-diagnosis through ongoing treatment on
a mobile digital platform.
Ray Pressburger, a managing director in Life Sciences for
Accenture said, “It’s an honor to be recognized by the IDC
MarketScape for the value we provide in life sciences sales and
marketing IT outsourcing services for our clients. The IDC
MarketScape report analysis shows that our deep industry knowledge
and breadth of experience allow us to bring insights, design
thinking, and human ingenuity together to transform sales and
marketing operating models and support our clients’ business
growth.”
Mike Townsend, research director for Life Science Commercial
Strategies at IDC Health Insights, says, "Life science companies
are embracing digital transformation efforts within sales and
marketing using a wide variety of digital technologies, including
AI, cloud computing, mobile technology, and social media and
analytics, and leveraging a host of internal and external data
sources. Highly experienced vendors like Accenture are offering
increasingly sophisticated ITO models for processes while enabling
their clients to focus on their core competencies — improve
outcomes for doctors and patients alike."
More information about why Accenture was named a Leader in the
IDC MarketScape report can be found here.
About IDC MarketScape IDC MarketScape vendor assessment
model is designed to provide an overview of the competitive fitness
of ICT (information and communications technology) suppliers in a
given market. The research methodology utilizes a rigorous scoring
methodology based on both qualitative and quantitative criteria
that results in a single graphical illustration of each vendor’s
position within a given market. IDC MarketScape provides a clear
framework in which the product and service offerings, capabilities
and strategies, and current and future market success factors of IT
and telecommunications vendors can be meaningfully compared. The
framework also provides technology buyers with a 360-degree
assessment of the strengths and weaknesses of current and
prospective vendors.
Accenture’s Life Sciences industry group helps pharmaceutical,
biotech, medical technology, distributor and consumer health
companies combine the latest technology with scientific
breakthroughs to revolutionize how medical treatments are
discovered, developed, and delivered to patients around the world.
To learn more, visit
https://www.accenture.com/us-en/industries/life-sciences-index.
About Accenture Accenture is a global professional
services company with leading capabilities in digital, cloud, and
security. Combining unmatched experience and specialized skills
across more than 40 industries, we offer Strategy and Consulting,
Interactive, Technology, and Operations services — all powered by
the world’s largest network of Advanced Technology and Intelligent
Operations centers. Our 699,000 people deliver on the promise of
technology and human ingenuity every day, serving clients in more
than 120 countries. We embrace the power of change to create value
and shared success for our clients, people, shareholders, partners,
and communities. Visit us at accenture.com.
Copyright ©2022 Accenture. All rights reserved. Accenture and
its logo are registered trademarks of Accenture.
This content is provided for general information purposes and is
not intended to be used in place of consultation with our
professional advisors. This document refers to marks owned by third
parties. All such third-party marks are the property of their
respective owners. No sponsorship, endorsement or approval of this
content by the owners of such marks is intended, expressed or
implied.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220428005137/en/
Marchell Gillis Accenture +1 678 657 7515
marchell.gillis@accenture.com
Accenture (NYSE:ACN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Accenture (NYSE:ACN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024